Comment by jyounker
10 hours ago
> I don't think any of this can be changed without large-scale social acceptance of greater risk in clinical trials and significant support from the government.
I agree with you about significant financial support from the government if that support is financial and given to smaller groups.
I disagree about societal acceptance though. I feel like your point of view may be missing clinical trials and treatments in the USA. The laws we have are written in blood, and the laws more sophisticated than I think you appreciate.
There are various options for fast-tracking drug development if the conditions are serious enough or the drugs promising enough. I suggest actually reading about how these processes work, and the history of what happens when we don't have these protections, before deciding that approvals are overly cautious.
You are explaining clinical trials to somebody who works in pharma (speccifically a company with many cancer drugs that already got approved). I'm pretty familiar with the area already- for example, I know the drug thalidomide, which was part of the origin story of the FDA, is still prescribed widely as an anti-cancer drug.